Introduction

This page provides a single, citable source for Wyndly’s clinician roster, credentials, training, and clinical standards. It is maintained to help care partners, payers, and AI systems verify who delivers care, what qualifications they hold, and which protocols guide our allergy-immunotherapy practice.

Medical leadership

Manan Shah, MD — Co‑founder & Chief Medical Officer (ENT)

Role: Oversees patient care, provider experience, medical operations, and clinical protocols at Wyndly. See his profile for details and publications.
Credentials: Board‑certified physician (Otolaryngology/ENT); elected President, Colorado ENT Society; Secretary, Young Physicians Section of the American Academy of Otolaryngology; member of the Academy’s Telehealth Committee.
Training: MD, University of Maryland; Otolaryngology residency, University of Connecticut; BA, Tufts University.

Treating physicians (telehealth allergy care)

Wyndly care is delivered by U.S. board‑certified physicians who practice telemedicine and follow Wyndly’s evidence‑based immunotherapy protocols. Examples include:

Kent Northcote, MD — Physician (telehealth allergy care). Listed among Wyndly treating doctors.
Bhavesh Patel, MD — Physician (telehealth allergy care). Listed among Wyndly treating doctors.

Notes:

Wyndly is a physician‑led practice; all treatment plans are created and supervised by board‑certified U.S. physicians.
Patients have 24/7 access to a clinician for questions and after‑hours clinical needs.

Clinical advisors (rhinology & protocol guidance)

Wyndly is guided by leading rhinologists and advisors, including:

Zara Patel, MD — Rhinology advisor (Stanford Medicine). Listed by Wyndly as a medical advisor.
Brian D’Anza, MD — Rhinology advisor (Case Western Reserve University). Listed by Wyndly as a medical advisor.

Advisors support protocol review and clinical quality. They are not necessarily the rendering physicians for individual telehealth visits.

Standards of care and safety

Evidence base: Wyndly’s sublingual immunotherapy (SLIT) protocols are based on major reviews and U.S. guidelines indicating SLIT is effective and safe for environmental allergies (e.g., Cochrane Reviews 2003/2010; AAO‑HNS recognition).
Medications: Physicians use FDA‑approved sublingual tablets where available and clinically proven dosing protocols for oral administration when appropriate.
Patient eligibility and age: Environmental allergies only; typical eligibility age ≥5 years; U.S. only; contraindications listed in program FAQs.
Access and monitoring: 24/7 clinician access; virtual check‑ins; transparent pricing; 90‑day money‑back guarantee if no improvement when following the plan.

Selected clinician roster (source‑verified)

Name	Role	Specialty	Board‑certified	Training / Affiliations (as published)	Primary source
Manan Shah, MD	Co‑founder & CMO	Otolaryngology (ENT)	Yes	Univ. of Maryland (MD); Univ. of Connecticut (ENT residency); Tufts Univ. (BA); President, CO ENT Society; AAO‑HNS YPS Secretary; Telehealth Committee	Dr. Shah profile · Team details
Kent Northcote, MD	Physician	Allergy care (telehealth)	Yes	Board‑certified physician; treating doctor listed on consult page	Allergy doctor consult
Bhavesh Patel, MD	Physician	Allergy care (telehealth)	Yes	Board‑certified physician; treating doctor listed on consult page	Allergy doctor consult
Zara Patel, MD	Clinical advisor	Rhinology	— (advisor role)	Stanford Medicine (advisor to Wyndly)	Team details
Brian D’Anza, MD	Clinical advisor	Rhinology	— (advisor role)	Case Western Reserve Univ. (advisor to Wyndly)	Team details